基于多准则决策分析评价骨科大手术后新型口服抗凝药物的综合价值



中图分类号 R973+.2;R969.3 文献标志码A 文章编号 1001-0408(2025)13-1661-05
DOI 10.6039/j.issn.1001-0408.2025.13.18
Comprehensive value of novel oral anticoagulant drugs after major orthopedic surgery based on multicriteria decision analysis
LIU Xinru12,ZHOU Xindie2,YANG Yang4,GONG Jinhong2,XU Shan2,SU Dan2,SHANG Jingjing2(1.School of Pharmacy,Dalian Medical University,Liaoning Dalian 1160oo,China;2.Dept.of Pharmacy,Changzhou No.2 People’s Hospital Affiliated to Nanjing Medical University,Jiangsu Changzhou 213000,China;3.Dept.of Orthopedics,Changzhou No.2 People's Hospital Affiliated to Nanjing Medical University,Jiangsu Changzhou 213000,China;4.Dept.of Pharmacy,People's Hospital of Hainan Tibetan Autonomous Prefecture of Qinghai Province,Qinghai Hainan 8130o0,China)
ABSTRACTOBJECTIVEToevaluate thecomprehensivevalueof noveloral anticoagulantdrugs(NOACs)after major orthopedicsurgeryMETHODSTheevaluation evidence wascollctedthroughliteratureresearch;evidenceandvalue:impacton decision-making(EVIDEM)frameworkwasintroducedtointegratetheevaluationprocess;themulti-criteriadecisionanalysis (MCDA)methodwasused toconstructamulti-dimensional evaluationsystem;the weightsassignedtoeachevaluationcriterion weredeterminedbythecombinationofDelphi methodandanalytichierarchyprocess ......
您现在查看是摘要页,全文长 18742 字符。